Immunocore Holdings (IMCR) Goodwill & Intangibles (2022)

Immunocore Holdings' (IMCR) quarterly Goodwill & Intangibles came in at $480900.6 in Q4 2022.

Immunocore Holdings (IMCR) Goodwill & Intangibles (2022) Analysis & Trends

Immunocore Holdings has disclosed Goodwill & Intangibles across 1 years of filings, most recently posting $480900.6 for Q4 2022.

  • Goodwill & Intangibles for Q4 2022 came in at $480900.6, changed N/A year-over-year; the trailing twelve-month figure through Dec 2022 was $480900.6 (changed N/A YoY), and the FY2022 annual result was $480900.6, changed N/A from the prior year.
  • Goodwill & Intangibles came in at $480900.6 for Q4 2022 at Immunocore Holdings.
  • In the past five years, Goodwill & Intangibles ranged from a high of $480900.6 in Q4 2022 to a low of $480900.6 in Q4 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
2 Belite Bio 55,234.00 Bn 55,234.00 Bn -
3 Quantum Biopharma 17,823.14 Bn 17,823.14 Bn -
4 Legend Biotech 3,624.50 Bn 3,624.21 Bn 242.10 Mn
5 Akari Therapeutics 1,745.73 Bn 1,745.73 Bn -
6 Evaxion A 1,540.85 Bn 1,540.84 Bn -
7 Psyence Biomedical 229.39 Bn 229.38 Bn -
8 Vertex Pharmaceuticals 112.57 Bn 105.33 Bn 2.59 Bn
9 Abivax 93.46 Bn 93.46 Bn -
10 Immunocore Holdings 1.46 Bn 616.35 Mn 106.24 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 480,900.61